On November 30, 2012 the US Supreme Court agreed to hear the appeal in the case of Association for Molecular Pathology v Myriad Genetics Inc. In particular, the Court limited its grant of the appeal to the first question posed by the petitioners: “Are human genes patentable?”
IP Osgoode would like to thank The Honourable Justice Marshall Rothstein and The Honourable Mr. Justice Roger T. Hughes for being a part of our speaker series. They both provided thought provoking commentary on intellectual property litigation from a judicial perspective. For those who were unable to attend our speaker series events in person, analysis […]
“I think it’s time for global peace,” said Justice Koh at the end the post-trial hearing in San Jose on Thursday. After hearing arguments from both Apple and Samsung, Justice Koh will begin her review of the $1.05 billion awarded to Apple by a jury in August.
On the afternoon of November 29th 2012 IP Osgoode was pleased to host Justice Roger T. Hughes of the Federal Court of Canada as he shared his experiences with us in a lecture entitled “Advocacy Skills and IP: Observations from the Bench”.
Lately, it seems as if every IP law and tech blog one reads has something new to report on one of the countless lawsuits Apple is engaged in around the world. This week was no exception – the biggest splash that Apple made in the news circuit this time around was that Apple had come […]
The Canadian pharmaceutical industry is entering a new era as Subsequent Entry Biologic (SEB) litigation begins to emerge in the Canadian pharmaceutical landscape. Biologic drugs are derived through the metabolic activity of living organisms and tend to be significantly more variable and structurally complex then chemically synthesized drugs.
Obesity and chronic diseases, like diabetes and heart disease, are on the rise. To solve this crisis, we seem to be searching for the next super food, known as functional food, which will lower our blood sugar, reduce hypertension, and make us lose five pounds.
On November 8, 2012 the Supreme Court of Canada (SCC) released its eagerly anticipated decision in the “Viagra Appeal”. In a unanimous decision written by Justice LeBel, the SCC found the patent at issue invalid for insufficient disclosure. This decision marks the end of a lengthy legal battle between Teva and Pfizer over the validity […]
Charles Duhigg and Steve Lohr, reporters for The New York Times, have published an insightful commentary on the current state of the patent system and, in particular, the state of software patents.
Having won the patent infringement battle in the High Court of Justice of England & Wales, Samsung is determined to win the war. Apple, however, is attempting to stave off the offensive by fighting to have a controversial court order stayed.